These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 35603379)

  • 21. Regulatory T cells are associated with the tumor immune microenvironment and immunotherapy response in triple-negative breast cancer.
    Huang P; Zhou X; Zheng M; Yu Y; Jin G; Zhang S
    Front Immunol; 2023; 14():1263537. PubMed ID: 37767092
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of necroptosis-related subtypes and prognosis model in triple negative breast cancer.
    Pu S; Zhou Y; Xie P; Gao X; Liu Y; Ren Y; He J; Hao N
    Front Immunol; 2022; 13():964118. PubMed ID: 36059470
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Therapy response and prognosis of patients with early breast cancer with low positivity for hormone receptors - An analysis of 2765 patients from neoadjuvant clinical trials.
    Villegas SL; Nekljudova V; Pfarr N; Engel J; Untch M; Schrodi S; Holms F; Ulmer HU; Fasching PA; Weber KE; Albig C; Heinrichs C; Marmé F; Hartmann A; Hanusch C; Schmitt WD; Huober J; Lederer B; van Mackelenbergh M; Tesch H; Jackisch C; Rezai M; Sinn P; Sinn BV; Hackmann J; Kiechle M; Schneeweiss A; Weichert W; Denkert C; Loibl S
    Eur J Cancer; 2021 May; 148():159-170. PubMed ID: 33743484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels tumour heterogeneity plus M2-like tumour-associated macrophage infiltration and aggressiveness in TNBC.
    Bao X; Shi R; Zhao T; Wang Y; Anastasov N; Rosemann M; Fang W
    Cancer Immunol Immunother; 2021 Jan; 70(1):189-202. PubMed ID: 32681241
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cancer stem cells in TNBC.
    Hua Z; White J; Zhou J
    Semin Cancer Biol; 2022 Jul; 82():26-34. PubMed ID: 34147641
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Glucocorticoid receptors orchestrate a convergence of host and cellular stress signals in triple negative breast cancer.
    Posani SH; Gillis NE; Lange CA
    J Steroid Biochem Mol Biol; 2024 Oct; 243():106575. PubMed ID: 38950871
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Landscape of toll-like receptors expression in tumor microenvironment of triple negative breast cancer (TNBC): Distinct roles of TLR4 and TLR8.
    Roychowdhury A; Jondhale M; Saldanha E; Ghosh D; Kumar Panda C; Chandrani P; Mukherjee N
    Gene; 2021 Aug; 792():145728. PubMed ID: 34022297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the heterogeneity of cancer-associated fibroblasts in TNBC.
    Wu X; Lu W; Zhang W; Zhang D; Mei H; Zhang M; Cui Y; Zhuo Z
    Aging (Albany NY); 2023 Nov; 15(21):12674-12697. PubMed ID: 37963845
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and biological heterogeneities in triple-negative breast cancer reveals a non-negligible role of HER2-low.
    Hu XE; Yang P; Chen S; Wei G; Yuan L; Yang Z; Gong L; He L; Yang L; Peng S; Dong Y; He X; Bao G
    Breast Cancer Res; 2023 Mar; 25(1):34. PubMed ID: 36998014
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of an immune-suppressed subtype of feline triple-negative basal-like invasive mammary carcinomas, spontaneous models of breast cancer.
    Dagher E; Simbault L; Abadie J; Loussouarn D; Campone M; Nguyen F
    Tumour Biol; 2020 Jan; 42(1):1010428319901052. PubMed ID: 31959092
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Single-cell analysis of tumor microenvironment and cell adhesion reveals that interleukin-1 beta promotes cancer cell proliferation in breast cancer.
    Wang W; Dong G; Yang Z; Li S; Li J; Wang L; Zhu Q; Wang Y
    Animal Model Exp Med; 2024 Oct; 7(5):617-625. PubMed ID: 38860503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive analysis and establishment of a prediction model of alternative splicing events reveal the prognostic predictor and immune microenvironment signatures in triple negative breast cancer.
    Yu S; Hu C; Liu L; Cai L; Du X; Yu Q; Lin F; Zhao J; Zhao Y; Zhang C; Liu X; Li W
    J Transl Med; 2020 Jul; 18(1):286. PubMed ID: 32723333
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Role of
    Chu J; Tang S; Li T; Fan H
    Front Biosci (Landmark Ed); 2024 Feb; 29(2):73. PubMed ID: 38420798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Identification of Key Genes Affecting the Tumor Microenvironment and Prognosis of Triple-Negative Breast Cancer.
    Yi J; Zhong W; Wu H; Feng J; Zouxu X; Huang X; Li S; Shuang Z
    Front Oncol; 2021; 11():746058. PubMed ID: 34745969
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MUC1-C integrates activation of the IFN-γ pathway with suppression of the tumor immune microenvironment in triple-negative breast cancer.
    Yamashita N; Long M; Fushimi A; Yamamoto M; Hata T; Hagiwara M; Bhattacharya A; Hu Q; Wong KK; Liu S; Kufe D
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33495298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ganetespib blocks HIF-1 activity and inhibits tumor growth, vascularization, stem cell maintenance, invasion, and metastasis in orthotopic mouse models of triple-negative breast cancer.
    Xiang L; Gilkes DM; Chaturvedi P; Luo W; Hu H; Takano N; Liang H; Semenza GL
    J Mol Med (Berl); 2014 Feb; 92(2):151-64. PubMed ID: 24248265
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Novel Platelet-Related Gene Signature for Predicting the Prognosis of Triple-Negative Breast Cancer.
    Xie J; Zou Y; Ye F; Zhao W; Xie X; Ou X; Xie X; Wei W
    Front Cell Dev Biol; 2021; 9():795600. PubMed ID: 35096824
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The molecular subtypes of triple negative breast cancer were defined and a ligand-receptor pair score model was constructed by comprehensive analysis of ligand-receptor pairs.
    Pan W; Song K; Zhang Y; Yang C; Zhang Y; Ji F; Zhang J; Shi J; Wang K
    Front Immunol; 2022; 13():982486. PubMed ID: 36119101
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unravelling subclonal heterogeneity and aggressive disease states in TNBC through single-cell RNA-seq.
    Karaayvaz M; Cristea S; Gillespie SM; Patel AP; Mylvaganam R; Luo CC; Specht MC; Bernstein BE; Michor F; Ellisen LW
    Nat Commun; 2018 Sep; 9(1):3588. PubMed ID: 30181541
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Delving into the Heterogeneity of Different Breast Cancer Subtypes and the Prognostic Models Utilizing scRNA-Seq and Bulk RNA-Seq.
    Xu J; Qin S; Yi Y; Gao H; Liu X; Ma F; Guan M
    Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077333
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.